Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Minority Interest (2018 - 2022)

Nephros has reported Minority Interest over the past 5 years, most recently at $3.3 million for Q4 2022.

  • Quarterly results put Minority Interest at $3.3 million for Q4 2022, up 7.69% from a year ago — trailing twelve months through Dec 2022 was $3.3 million (up 7.69% YoY), and the annual figure for FY2022 was $3.3 million, up 7.69%.
  • Minority Interest for Q4 2022 was $3.3 million at Nephros, roughly flat from $3.3 million in the prior quarter.
  • Over the last five years, Minority Interest for NEPH hit a ceiling of $3.3 million in Q4 2022 and a floor of $3.0 million in Q3 2018.
  • Median Minority Interest over the past 5 years was $3.1 million (2020), compared with a mean of $3.1 million.
  • Biggest five-year swings in Minority Interest: grew 0.07% in 2021 and later grew 7.69% in 2022.
  • Nephros' Minority Interest stood at $3.0 million in 2018, then grew by 0.47% to $3.0 million in 2019, then grew by 1.23% to $3.1 million in 2020, then rose by 0.1% to $3.1 million in 2021, then rose by 7.69% to $3.3 million in 2022.
  • The last three reported values for Minority Interest were $3.3 million (Q4 2022), $3.3 million (Q3 2022), and $3.3 million (Q2 2022) per Business Quant data.